$AEHR
AEHR TEST SYSTEMS Stock $aehr

$aehr Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000165495422013771 Filed on October 14, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q3
Revenue	$10.67M	$20.29M	$5.646M
YoY Change	89.0%	165.63%	180.62%
Cost Of Revenue	$6.190M	$9.821M	$3.365M
YoY Change	83.95%	139.3%	88.52%
Gross Profit	$4.481M	$10.47M	$2.281M
YoY Change	96.45%	196.21%	904.85%
Gross Profit Margin	41.99%	51.59%	40.4%
Selling, General & Admin	$2.525M	$2.993M	$1.953M
YoY Change	29.29%	57.2%	29.0%
% of Gross Profit	56.35%	28.59%	85.62%
Research & Development	$1.498M	$1.655M	$1.321M
YoY Change	13.4%	60.84%	46.78%
% of Gross Profit	33.43%	15.81%	57.91%
Depreciation & Amortization	$89.00K	$81.00K	$73.00K
YoY Change	21.92%	15.71%	-8.75%
% of Gross Profit	1.99%	0.77%	3.2%
Operating Expenses	$4.023M	$4.648M	$3.274M
YoY Change	22.88%	58.47%	35.63%
Operating Profit	$458.0K	$5.820M	-$993.0K
YoY Change	-146.12%	868.39%	-54.6%
Interest Expense	$121.0K	$22.00K	$9.000K
YoY Change	1244.44%	-300.0%	-30.77%
% of Operating Profit	26.42%	0.38%
Other Income/Expense, Net	$24.00K	-$38.00K	$23.00K
YoY Change	4.35%	65.22%	-124.47%
Pretax Income	$603.0K	$5.804M	$719.0K
YoY Change	-16.13%	923.63%	-765.74%
Income Tax	$14.00K	$10.00K	-$23.00K
% Of Pretax Income	2.32%	0.17%	-3.2%
Net Earnings	$589.0K	$5.794M	$696.0K
YoY Change	-15.37%	921.87%	550.47%
Net Earnings / Revenue	5.52%	28.56%	12.33%
Basic Earnings Per Share	$0.02	$0.21	$0.03
Diluted Earnings Per Share	$20.46K	$0.20	$0.03
COMMON SHARES
Basic Shares Outstanding	27.34M shares		24.00K shares
Diluted Shares Outstanding	28.79M shares		25.36K shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$36.15M	$31.48M	$6.530M
YoY Change	453.55%	587.12%	3.49%
Cash & Equivalents	$36.15M	$31.48M	$6.530M
Short-Term Investments
Other Short-Term Assets	$833.0K	$613.0K	$759.0K
YoY Change	9.75%	11.25%	72.5%
Inventory	$17.23M	$15.05M	$10.15M
Prepaid Expenses
Receivables	$5.116M	$12.86M	$4.264M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$59.33M	$60.01M	$21.70M
YoY Change	173.42%	212.8%	35.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.062M	$1.203M	$676.0K
YoY Change	205.03%	77.7%	-73.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$187.0K	$201.0K	$189.0K
YoY Change	-1.06%	1.52%	26.0%
Total Long-Term Assets	$2.249M	$2.321M	$2.302M
YoY Change	-2.3%	-6.45%	-15.37%
TOTAL ASSETS
Total Short-Term Assets	$59.33M	$60.01M	$21.70M
Total Long-Term Assets	$2.249M	$2.321M	$2.302M
Total Assets	$61.58M	$62.33M	$24.00M
YoY Change	156.56%	187.69%	28.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.387M	$4.195M	$2.753M
YoY Change	23.03%	45.01%	239.88%
Accrued Expenses	$3.220M	$3.610M	$1.978M
YoY Change	62.79%	66.9%	-3.04%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$9.899M	$11.01M	$8.760M
YoY Change	13.0%	21.55%	110.07%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$161.0K	$44.00K	$46.00K
YoY Change	250.0%	-10.2%	-96.83%
Total Long-Term Liabilities	$161.0K	$44.00K	$46.00K
YoY Change	250.0%	-10.2%	-97.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.899M	$11.01M	$8.760M
Total Long-Term Liabilities	$161.0K	$44.00K	$46.00K
Total Liabilities	$10.06M	$11.34M	$9.769M
YoY Change	2.98%	10.99%	53.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$66.27M	-$66.86M	-$75.62M
YoY Change	-12.36%	-12.38%
Common Stock	$117.9M	$271.0K	$245.0K
YoY Change	48039.59%	-99.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$51.52M	$50.99M	$14.23M
YoY Change
Total Liabilities & Shareholders Equity	$61.58M	$62.33M	$24.00M
YoY Change	156.56%	187.69%	28.42%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q3
OPERATING ACTIVITIES
Net Income	$589.0K	$5.794M	$696.0K
YoY Change	-15.37%	921.87%	550.47%
Depreciation, Depletion And Amortization	$89.00K	$81.00K	$73.00K
YoY Change	21.92%	15.71%	-8.75%
Cash From Operating Activities	$5.461M	-$767.0K	$1.874M
YoY Change	191.41%	301.57%	191.45%
INVESTING ACTIVITIES
Capital Expenditures	$84.00K	-$198.0K	$59.00K
YoY Change	42.37%	1064.71%	25.53%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$84.00K	-$198.0K	-$59.00K
YoY Change	42.37%	1064.71%	25.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$724.0K	361.0K	$135.0K
YoY Change	-636.3%	351.25%	-28.95%
NET CHANGE
Cash From Operating Activities	$5.461M	-767.0K	$1.874M
Cash From Investing Activities	-$84.00K	-198.0K	-$59.00K
Cash From Financing Activities	-$724.0K	361.0K	$135.0K
Net Change In Cash	$4.663M	-604.0K	$1.948M
YoY Change	139.37%	371.87%	121.36%
FREE CASH FLOW
Cash From Operating Activities	$5.461M	-$767.0K	$1.874M
Capital Expenditures	$84.00K	-$198.0K	$59.00K
Free Cash Flow	$5.377M	-$569.0K	$1.815M
YoY Change	196.25%	227.01%	204.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1203000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3387000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4195000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	740000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	917000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	187000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	201000	usd
CY2022Q3	us-gaap	Assets Assets	61578000	usd
CY2022Q2	us-gaap	Assets Assets	62328000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5116000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12859000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	17233000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	15051000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	833000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	613000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	59329000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	60007000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1322000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	4481000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	2281000	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	3365000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	44000	usd
CY2022Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2022Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001040470
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27120000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27395000	shares
CY2022Q2	aehr	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0	usd
CY2022Q3	aehr	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	80000	usd
CY2022Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	0	usd
CY2022Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	0	usd
CY2022Q3	dei	Document Type DocumentType	10-Q
CY2022Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-08-31
CY2022Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	dei	Entity File Number EntityFileNumber	000-22893
CY2022Q3	dei	Entity Registrant Name EntityRegistrantName	AEHR TEST SYSTEMS
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
CY2022Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-2424084
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Kato Terrace
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
CY2022Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94539
CY2022Q3	dei	City Area Code CityAreaCode	510
CY2022Q3	dei	Local Phone Number LocalPhoneNumber	623-9400
CY2022Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q3	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Security12b Title Security12bTitle	Common Stock Par value $0.01 per share
CY2022Q3	dei	Trading Symbol TradingSymbol	AEHR
CY2022Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27495356	shares
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2479000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3610000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	741000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	794000	usd
CY2022Q3	aehr	Customer Deposits And Deferred Revenue Short Term CustomerDepositsAndDeferredRevenueShortTerm	3292000	usd
CY2022Q2	aehr	Customer Deposits And Deferred Revenue Short Term CustomerDepositsAndDeferredRevenueShortTerm	2415000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9899000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11014000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	73000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	212000	usd
CY2022Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	47000	usd
CY2022Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	69000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	10060000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	11339000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27395000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27120000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	274000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	117668000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-150000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-66274000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	51518000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61578000	usd
CY2022Q3	us-gaap	Revenues Revenues	10671000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	6190000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2525000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1953000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1498000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1321000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4023000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	3274000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	458000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-993000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	121000	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9000	usd
CY2022Q3	aehr	Gain From Forgiveness Of Ppp Loan GainFromForgivenessOfPppLoan	0	usd
CY2021Q3	aehr	Gain From Forgiveness Of Ppp Loan GainFromForgivenessOfPppLoan	1698000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	24000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	603000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	719000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	589000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	696000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27242000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23999000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28788000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25356000	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	589000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	696000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-45000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-36000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	544000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	660000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	50989000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	455000	usd
CY2022Q3	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1179000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	709000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	589000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-45000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	51518000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	11449000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1535000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	588000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	696000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-36000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	14232000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	589000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	696000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	710000	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	588000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	89000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	73000	usd
CY2022Q3	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	usd
CY2021Q3	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	1698000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7648000	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	895000	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2323000	usd
CY2021Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1324000	usd
CY2022Q3	aehr	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	-210000	usd
CY2021Q3	aehr	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	-201000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-769000	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-130000	usd
CY2022Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1130000	usd
CY2021Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-169000	usd
CY2022Q3	aehr	Increase Decrease In Customer Deposits And Deferred Revenue IncreaseDecreaseInCustomerDepositsAndDeferredRevenue	855000	usd
CY2021Q3	aehr	Increase Decrease In Customer Deposits And Deferred Revenue IncreaseDecreaseInCustomerDepositsAndDeferredRevenue	3141000	usd
CY2022Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2000	usd
CY2021Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5461000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1874000	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	84000	usd
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	59000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-59000	usd
CY2022Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2021Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1400000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	455000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1535000	usd
CY2022Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1179000	usd
CY2021Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	135000	usd
CY2021Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1948000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6610000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2071000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	192000	usd
CY2022Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:45px">ACCOUNTING ESTIMATES. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used to account for sales and revenue allowances, the allowance for doubtful accounts, inventory valuations, income taxes, stock-based compensation expenses, and product warranties, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances. Actual results could differ materially from those estimates.</p>
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0540	pure
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	189000	usd
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	192000	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	119000	shares
CY2021Q3	aehr	Maximum Amount Of Rs Us To Be Vested If All Revenue Goals Are Achieved MaximumAmountOfRSUsToBeVestedIfAllRevenueGoalsAreAchieved	316000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.93
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10671000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5646000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10671000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5646000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10671000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5646000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3339000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2484000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	589000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	696000	usd
CY2022Q3	aehr	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	27242000	shares
CY2021Q3	aehr	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	23999000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27242000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23999000	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1546000	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1357000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28788000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25356000	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	34733000	usd
CY2022Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	28609000	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	80000	usd
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12292000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9507000	usd
CY2022Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4941000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5461000	usd
CY2022Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	83000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	17233000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	15051000	usd
CY2022Q3	aehr	Provision For Income Tax ProvisionForIncomeTax	14000000	usd
CY2022Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	410000	usd
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	494000	usd
CY2022Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	118000	usd
CY2021Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	162000	usd
CY2022Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	61000	usd
CY2021Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	0	usd
CY2022Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	165000	usd
CY2021Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	151000	usd
CY2022Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	424000	usd
CY2021Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	505000	usd
CY2022Q3	aehr	Customer Deposits CustomerDeposits	3138000	usd
CY2022Q2	aehr	Customer Deposits CustomerDeposits	2263000	usd
CY2022Q3	aehr	Deferred Revenues DeferredRevenues	154000	usd
CY2022Q2	aehr	Deferred Revenues DeferredRevenues	152000	usd
CY2022Q3	aehr	Customer Deposits And Deferred Revenue CustomerDepositsAndDeferredRevenue	3292000	usd
CY2022Q2	aehr	Customer Deposits And Deferred Revenue CustomerDepositsAndDeferredRevenue	2415000	usd
CY2021Q3	aehr	Provision For Income Tax ProvisionForIncomeTax	23000000	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	206000	usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	203000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	623000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	168000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	32000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	19000	usd
CY2022Q3	aehr	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	0	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	842000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	28000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	814000	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1902000	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y1M6D
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	159000	shares
CY2022Q3	aehr	Maximum Amount Of Rs Us To Be Vested If All Revenue Goals Are Achieved MaximumAmountOfRSUsToBeVestedIfAllRevenueGoalsAreAchieved	114000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.00
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	710000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	588000	usd
CY2022Q3	aehr	Sotck Based Compensation Costs Capitalized As Part Of Inventory SotckBasedCompensationCostsCapitalizedAsPartOfInventory	85000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	764000	usd
CY2021Q3	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	40000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	442000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	240000	shares
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1322000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1203000	usd

Files In Submission

Name	View Source	Status
0001654954-22-013771-index-headers.html	Edgar Link	pending
0001654954-22-013771-index.html	Edgar Link	pending
0001654954-22-013771.txt	Edgar Link	pending
0001654954-22-013771-xbrl.zip	Edgar Link	pending
aehr-20220831.xsd	Edgar Link	pending
aehr-20220831_cal.xml	Edgar Link	unprocessable
aehr-20220831_def.xml	Edgar Link	unprocessable
aehr_10q.htm	Edgar Link	pending
aehr_ex311.htm	Edgar Link	pending
aehr_ex312.htm	Edgar Link	pending
aehr_ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
aehr-20220831_lab.xml	Edgar Link	unprocessable
aehr-20220831_pre.xml	Edgar Link	unprocessable
aehr_10q_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AEHR
AEHR TEST SYSTEMS Stock $aehr

2022 Q3 Form 10-Q Financial Statement

#000165495422013771 Filed on October 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AEHR AEHR TEST SYSTEMS Stock $aehr

2022 Q3 Form 10-Q Financial Statement

#000165495422013771 Filed on October 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AEHR
AEHR TEST SYSTEMS Stock $aehr